title: Hormone therapy in postmenopausal women and risk of endometrial hyperplasia: a Cochrane review summary.
authors.affiliation: Department of Obstetrics and Gynaecology, University of Auckland, New Zealand. Electronic address: h.roberts@auckland.ac.nz.
authors.forename: Helen
authors.initials: H
authors.lastname: Roberts
authors.affiliation: Department of Obstetrics and Gynaecology, University of Melbourne, Australia.
authors.forename: Martha
authors.initials: M
authors.lastname: Hickey
authors.affiliation: Cochrane Menstrual Disorders and Subfertility Group, Department of Obstetrics and Gynaecology, University of Auckland, New Zealand.
authors.forename: Anne
authors.initials: A
authors.lastname: Lethaby
mesh_terms: D004714:Endometrial Hyperplasia / Q000209:etiology / Q000517:prevention & control; D015914:Estrogen Replacement Therapy / Q000009:adverse effects; D004967:Estrogens / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D006801:Humans; D017698:Postmenopause; D011372:Progestins / Q000008:administration & dosage* / Q000627:therapeutic use; D012306:Risk
chemical_list: D004967:Estrogens; D011372:Progestins
keywords: Endometrial hyperplasia; Hormone therapy; Menopause